Antiphospholipid syndrome in children

Current Opinion in Rheumatology

Volumn 20, Issue 5, 2008, Pages 595-600

  Avčin, Tadej ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Children; Neonates

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; AGE DISTRIBUTION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; AUTOIMMUNE DISEASE; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; CEREBROVASCULAR DISEASE; CHICKENPOX; CHILD; CHILDHOOD DISEASE; CHOREA; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; EPILEPSY; ERYTHEMA INFECTIOSUM; FULMINATING PURPURA; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHERITANCE; LEMIERRE SYNDROME; LIVEDO RETICULARIS; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; MYELITIS; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; PARVOVIRUS; PLACENTAL TRANSFER; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; SKIN MANIFESTATION; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VALVULAR HEART DISEASE; VARICELLA ZOSTER VIRUS; VEIN THROMBOSIS; IMMUNOLOGY; NEWBORN; REGISTER; THROMBOSIS;

ANTIPHOSPHOLIPID SYNDROME; CHILD; HUMANS; INFANT, NEWBORN; REGISTRIES; RISK FACTORS; THROMBOSIS;

EID: 55249124289     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e3283060a8c     Document Type: Review

References (53)

1. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346:752-763.
2. Mackworth-Young CG. Antiphospholipid syndrome: multiple mechanisms. Clin Exp Immunol 2004; 136:393-401.
3. Vega-Ostertag ME, Pierangeli SS. Mechanisms of aPL-mediated thrombosis: effects of aPL on endothelium and platelets. Curr Rheumatol Rep 2007; 9:190-197.
4. O'Neil K. Role of complement in antiphospholipid antibody-mediated thrombosis. Curr Rheumatol Rep 2007; 9:205-211.
5. Cimaz R, Descloux E. Pediatric antiphospholipid syndrome. Rheum Dis Clin North Am 2006; 32:553-573.
6. Ravelli A, Martini A. Antiphospholipid syndrome in pediatrics. Rheum Dis Clin North Am 2007; 33:499-523. Detailed review of antiphospholipid syndrome in pediatric population.
7. Avĉin T, Silverman ED. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus 2007; 16:627-633.
8. Avĉin T, Cimaz R. Pediatric antiphospholipid syndrome. In: Cimaz R, Lehman T, editors. Pediatrics in systemic autoimmune diseases. Amsterdam: Elsevier; 2008. pp. 169-180. Comprehensive and updated review on clinical and immunological features, differential diagnosis, and treatment in pediatric patients with APS.
9. Beardsely DS. Venous thromboembolism in the neonatal period. Semin Perinatol 2007; 31:250-253.
10. Grabowski EF, Buonanno FS, Krishnamoorthy K. Prothrombotic risk factors in the evaluation and management of perinatal stroke. Semin Perinatol 2007; 31:243-249.
11. Boffa M-C, Lachassine E. Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus 2007; 16:634-641. This study evaluated clinical and laboratory features of 16 infants with perinatal thrombosis and positive aPLs. This is the largest collection of patients with neonatal APS.
12. Paro-Panjan D, Kitanovski L, Avĉin T. Neonatal antiphospholipid syndrome associated with heterozygous methylentetrahydrofolate reductase C677T and prothrombin G20210A gene mutations. Rheumatology 2007; 46:720-721.
13. Curry CJ, Bhullar S, Holmes J, et al. Risk factors for perinatal arterial stroke: a study of 60 mother-child pairs. Pediatr Neurol 2007; 37:99-107.
14. Lachassinne E, Motta M, De Carolis MP, et al. Clinical follow up of babies born to mothers with APS. Clin Exp Rheumatol 2007; 25:34. (abstract P143).
15. Nacinovich R, Galli J, Bomba M, et al. Neuropsychological development of children born to patients with antiphospholipid syndrome. Arthritis Rheum 2008; 59:345-351. The first study that demonstrated possible neurodevelopmental changes, particularly learning disabilities, in children born to mothers with positive aPLs.
16. 2 glycoprotein I antibodies bind to central nervous system. J Neurol Sci 1998; 156:211-219.
17. Meroni PL, Tincani A, Sepp N, et al. Endothelium and the brain in CNS lupus. Lupus 2003; 12:919-928.
18. Shrot S, Katzav A, Korczyn AD, et al. Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. Lupus 2002; 11:736-743.
19. Shoenfeld Y, Nahum A, Korczyn AD, et al. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 2003; 12:436-442.
20. 2glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study. Am J Perinatol 2006; 23:247-252.
21. 2 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology 2001; 40:565-573.
22. 2 glycoprotein I antibodies in children with atopic dermatitis. Int Immunol 2002; 14:823-830.
23. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost 2006; 4:295-306.
24. Berkun Y, Padeh S, Barash J, et al. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum 2006; 55:850-855.
25. Tavil B, Ozyurek E, Gumruk F, et al. Antiphospholipid antibodies in Turkish children with thrombosis. Blood Coagul Fibrinolysis 2007; 18:347-352.
26. Avĉin T, Cimaz R, Silverman ED, et al. Register for pediatric patients with antiphospholipid syndrome: clinical and immunological features of107children. Arthritis Rheum 2007; 56:S830 (abstract 2179).
27. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46:1019-1027.
28. Garcia-Carrasco M, Galarza C, Gómez-Ponce M, et al. Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients. Lupus 2007; 16:366-373.
29. Harel L, Sandborg C, Lee T, von Scheven E. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. J Rheumatol 2006; 33:1873-1877.
30. Avĉin T, Benseler SM, Tyrrell PN, et al. A follow-up study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus. Arthritis Rheum 2008; 59:206-213. A large cohort study of aPLs and associated neuropsychiatric manifestations in children with SLE. The study suggests an association between lupus anticoagulants and cerebrovascular disease and chorea.
31. Gidwani P, Segal E, Shanske A, Driscoll C. Chorea associated with antiphospholipid antibodies in a patient with Kabuki syndrome. Am J Med Genet A 2007; 143:1338-1341.
32. Wu SW, Graham B, Gelfand MJ, et al. Clinical and positron emission tomography findings of chorea associated with primary antiphospholipid antibody syndrome. Mov Disord 2007; 22:1813-1815.
33. Gattorno M, Falcini F, Ravelli A, et al. Outcome of primary antiphospholipid syndrome in childhood. Lupus 2003; 12:449-453.
34. Tarr T, Lakos G, Bhattoa HP, et al. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus. Lupus 2007; 16:324-328.
35. Kamat AV, D'Cruz DP, Hunt BJ. Managing antiphospholipid antibodies and antiphospholipid syndrome in children. Haematologica 2006; 91:1674-1680.
36. Ruiz-Irastorza G, Hunt BJ, Khamashta MA. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis Rheum 2007; 57:1487-1495.
37. Male C, Foulon D, Hoogendoorn H, et al. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patientswith systemic lupus erythematosus. Blood2005; 106:4152-4158.
38. Descloux E, Durieu I, Cochat P, et al. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies. Rheumatology 2008; 47: 183-187. The study provides evidence that aPLs may act as a risk factor for irreversible disease damage in pediatric SLE.
39. Brunner HI, Silverman ED, To T, et al. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002; 46:436-444.
40. Mikdashi J, Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology 2004; 43:1555-1560.
41. Cervera R, Font J, Gomez-Puerta JA, et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 2005; 64:1205-1209.
42. Olivier C, Blondiaux E, Blanc T, et al. Catastrophic antiphospholipid syndrome and pulmonary embolism in a 3-year-old child. Pediatr Radiol 2006; 36:870-873.
43. Park JM, Shin JI, Shin YH, et al. Catastrophic antiphospholipid syndrome in a 7-year-old girl. Clin Rheumatol 2007; 26:1011-1013.
44. Asherson RA, Pierangeli S, Cervera R. Microangiopathic antiphospholipid- associated syndromes revisited - new concepts relating to antiphospholipid antibodies and syndromes. J Rheumatol 2007; 34:1793-1794.
45. Megliĉ A, Grosek Ŝ, Benedik-Dolniĉar M, Avĉin T. Atypical hemolytic uremic syndrome complicated by microangiopathic antiphospholipid- associated syndrome. Lupus 2008; 17 (in press).
46. Shoenfeld Y, Blank M, Cervera R, et al. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 2006; 65:2-6.
47. Avĉin T, Toplak N. Antiphospholipid antibodies in response to infection. Curr Rheumatol Rep 2007; 9:212-218. A comprehensive review of clinical and experimental data for an infectious origin of APS.
48. Witmer CM, Steenhoff AP, Shah SS, Raffini LJ. Mycoplasma pneumoniae, splenic infarct, and transient antiphospholipid antibodies: a new association? Pediatrics 2007; 119:e292-e295.
49. Brown SMN, Padley S, Bush A, et al. Mycoplasma pneumonia and pulmonary embolism in a child due to acquired prothrombotic factors. Pediatr Pulmonol 2008; 43:200-202.
50. Losurdo G, Giacchino R, Castagnola E, et al. Cerebrovascular disease and varicella in children. Brain Dev 2006; 28:366-370.
51. Josephson C, Nuss R, Jacobson L, et al. The varicella-autoantibody syndrome. Pediatr Res 2001; 50:345-352.
52. Campanelli A, Kaya G, Ozsahin AH, et al. Purpura fulminans in a child as a complication of chickenpox infection. Dermatology 2004; 208:262-264.
53. Goldenberg NA, Knapp-Clevenger R, Hays T, Manco-Johnson MJ. Lemierre's and Lemierre's-like syndromes in children: survival and thromboembolic outcomes. Pediatrics 2005; 116:543-548.